Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?

[1]  N. Aksoy,et al.  Does a risky outcome of antenatal screening test indicate oxidative stress? , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  H. Niknejad,et al.  Human amniotic epithelial cells induce apoptosis of cancer cells: a new anti-tumor therapeutic strategy. , 2014, Cytotherapy.

[3]  R. Reiter,et al.  Melatonin: The watchdog of villous trophoblast homeostasis against hypoxia/reoxygenation-induced oxidative stress and apoptosis , 2013, Molecular and Cellular Endocrinology.

[4]  K. Schulze-Osthoff,et al.  Increased plasma levels of CK-18 as potential cell death biomarker in patients with HELLP syndrome , 2013, Cell Death and Disease.

[5]  D. Duranyıldız,et al.  Serum M65 as a biomarker for metastatic renal cell carcinoma. , 2013, Clinical genitourinary cancer.

[6]  F. Tas,et al.  A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer , 2013, Cancer Chemotherapy and Pharmacology.

[7]  A. Bilici,et al.  The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer , 2013, Medical Oncology.

[8]  N. Sebire,et al.  Histopathological features of biparental complete hydatidiform moles in women with NLRP7 mutations. , 2013, Placenta.

[9]  A. Bilici,et al.  The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer , 2012, Tumor Biology.

[10]  A. Bilici,et al.  Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls , 2012, Clinical and Translational Oncology.

[11]  Jeffrey Cummings,et al.  Application of the β-expectation tolerance interval to method validation of the M30 and M65 ELISA cell death biomarker assays. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Xin Lu,et al.  Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome , 2011, Modern Pathology.

[13]  M. Longtine,et al.  Review: Oxygen and trophoblast biology--a source of controversy. , 2011, Placenta.

[14]  A. Bilici,et al.  Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer? , 2011, Cancer Chemotherapy and Pharmacology.

[15]  N. Aksoy,et al.  Oxidative Stress Increased in Healthcare Workers Working 24-Hour On-Call Shifts , 2010, The American journal of the medical sciences.

[16]  I. Crocker,et al.  Placental Apoptosis in Health and Disease , 2010, American journal of reproductive immunology.

[17]  H. Çelik,et al.  Assessment of preoperative serum prolidase activity in epithelial ovarian cancer. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[18]  E. Ogris,et al.  Circulating Cytokeratin 18 Fragment M65—A Potential Marker of Malignancy in Colorectal Cancer Patients , 2009, Journal of Gastrointestinal Surgery.

[19]  B. Sancak,et al.  Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. , 2009, International immunopharmacology.

[20]  M. K. Siu,et al.  P63 Expression in Gestational Trophoblastic Disease: Correlation With Proliferation and Apoptotic Dynamics , 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[21]  I. Crocker,et al.  Epidermal growth factor rescues trophoblast apoptosis induced by reactive oxygen species , 2007, Apoptosis.

[22]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[23]  M. Harma,et al.  Defective placentation and resultant oxidative stress play a similar role in complete hydatidiform mole to that in preeclampsia and early pregnancy loss. , 2006, Medical hypotheses.

[24]  Sajal Gupta,et al.  Role of oxidative stress in female reproduction , 2005, Reproductive biology and endocrinology : RB&E.

[25]  O. Erel,et al.  Increased DNA damage in patients with complete hydatidiform mole. , 2005, Mutation research.

[26]  G. Saed,et al.  Expression pattern and regulation of genes differ between fibroblasts of adhesion and normal human peritoneum , 2005, Reproductive biology and endocrinology : RB&E.

[27]  A. Cheung,et al.  Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase‐related M30 CytoDeath antibody , 2001, Histopathology.